Vehicle topical gel
Vehicle topical gel is a pharmaceutical drug with 9 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
5
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
8 of 8 finished
0.0%
0 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts
Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex
Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers
Topical Ionic Contra-Viral Therapy in Actinic Keratosis
Phase II Study of AP0302 5% Versus a Vehicle Comparator
Clinical Trials (9)
A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts
Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex
Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers
Topical Ionic Contra-Viral Therapy in Actinic Keratosis
Phase II Study of AP0302 5% Versus a Vehicle Comparator
Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN
Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9